Bortezomib/Daratumumab/Dexamethasone/Thalidomide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, daratumumab, dexamethasone and thalidomide that can be used for the treatment of plasma cell (multiple) myeloma.

**Synonyms:** - Bortezomib-Daratumumab-Dexamethasone-Thalidomide - Bortezomib-Daratumumab-Dexamethasone-Thalidomide Regimen - Bortezomib-Thalidomide-Dexamethasone Plus Daratumumab - Bortezomib/Daratumumab/Dexamethasone/Thalidomide - Bortezomib/Thalidomide/Dexamethasone Plus Daratumumab - Bortezomib/Thalidomide/Dexamethasone Plus Daratumumab Regimen - Dara-VTD - Dara-VTD - Darzalex Plus VTD - Darzalex-VTD Regimen - VTD Regimen Plus Daratumumab - VTD-Darzalex - Velcade/Thalidomide/Dexamethasone/Darzalex